Month: May 2024

LOS ANGELES, May 07, 2024 (GLOBE NEWSWIRE) --  BlackLine, Inc. (Nasdaq: BL), today announced financial results for the first quarter...

Contacts Media Contact Len Dieterle AspenTech +1 781-221-4291 len.dieterle@aspentech.com Investor Contact Brian Denyeau ICR +1 646-277-1251 ir@aspentech.com Aspen Technology, Inc....

First Quarter Net Loss Improved by 80.0% Year Over Year and Adjusted EBITDA Loss Improved by 38.4%Affirms Second Half 2024...

Total revenue grew 27% to $138 million, with 30% growth in surgical revenue Adjusted EBITDA margin expanded 450 basis points...

RICHMOND, Va., May 07, 2024 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company...

FISHERS, IN / ACCESSWIRE / May 7, 2024 / American Resources Corporation's (NASDAQ:AREC) ("American Resources" or the "Company") ReElement Technologies...

Increasing Full Year 2024 Revenue and Adjusted EBITDA Guidance Driven by Strong First Quarter Performance CHARLES TOWN, W.Va., May 7,...

Contacts Investor and media inquiries: The Blueshirt Group Gary Dvorchak, CFA In US +1 323 240 5796 In China +86...

NEW YORK, May 7, 2024 /PRNewswire/ -- IAC (NASDAQ: IAC) posted its first quarter financial results and a letter to...

MAUMEE, Ohio, May 7, 2024 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces financial results for the first quarter ended March 31,...

SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that...

- Progressing ATI-2138 into Atopic Dermatitis -- Management to Host Conference Call at 5:00 PM ET Today -WAYNE, Pa., May...

Contacts Investors: Myesha Lacy ir@arcellx.com 510-418-2412 Media: Andrea Cohen Sam Brown Inc. andreacohen@sambrown.com 917-209-7163 Arcellx, Inc. (NASDAQ: ACLX), a biotechnology...

CHARLOTTESVILLE, Va., May 07, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical...

Contacts Inquiries Media: Kathleen Reid: media@abcellera.com, +1(236)521-6774 Business Development: Murray McCutcheon, Ph.D., bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie Solomon, ir@abcellera.com, +1(778)729-9116...

GAAP Revenue of $310.1 million Grows 3% year-over-year GAAP Operating Margin of 14% and Adjusted Operating Income Margin of 39%...

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that...

Contacts Price Karr 702-770-7555 investorrelations@wynnresorts.com Wynn Resorts, Limited (NASDAQ: WYNN) ("Wynn Resorts" or the "Company") today reported financial results for...

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on...

– Enrollment completed for Phase 2 trial evaluating iluzanebart in ALSP; Next data readout planned for Q3 2024 –– Phase...

Grew total revenue to $96.8 million, an increase of 17% Grew testing revenue by 25% Conference call and webcast today...

Contacts Press press@upstart.com Investors Jason Schmidt Vice President, Investor Relations ir@upstart.com Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence...

First Quarter Net Income of $0.52 per Diluted Share and Adjusted Operating Income of $0.56 per Diluted ShareRead more at...

CARLSBAD, Calif., May 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation...

DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on...

SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- TPI Composites, Inc., (TPI) (Nasdaq: TPIC) today announced a groundbreaking initiative in...

FOSTER CITY, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

Contacts Savara Inc. IR & PR Anne Erickson anne.erickson@savarapharma.com (512) 851-1366 Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company...

EVO ICL™ Continues to Outpace Refractive Industry Growth Record Quarterly U.S. Sales and Multiple Strategic Agreements Secured Reiterates Fiscal 2024...

Q1 Revenue Grew to $43.0 Million, Surpassing 91% Recurring RevenueGAAP Gross Margin Expands to 67%; Adjusted Gross Margin Rises to...

2024 Q1 highlights compared to the corresponding period of 2023: SANTA CLARA, Calif., May 7, 2024 /PRNewswire/ -- Semler Scientific, Inc....

LOUISVILLE, Colo., May 07, 2024 (GLOBE NEWSWIRE) -- Solid Power, Inc. (Nasdaq: SLDP), a leading developer of solid-state battery technology,...

LOUISVILLE, Colo., May 07, 2024 (GLOBE NEWSWIRE) -- Solid Power, Inc. (Nasdaq: SLDP), a leading developer of solid-state battery technology,...

– Quarterly Revenue of $90.8 million –– Gross Margin of 40.2% –– Net Income of $4.8 million –– Adjusted EBITDA of...

– Total net sales of $138.8 million up from $130.8 million in prior year first quarter –– Net income of $3.9 million up from $0.9 million...

BURLINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...

Delivered Total and Net Investment Income of $40.0 million and $18.7 million, RespectivelyInvestment Portfolio of $1.0 billionChairman, President and CEO...

LAS VEGAS, May 7, 2024 /PRNewswire/ -- Red Rock Resorts, Inc. ("Red Rock Resorts," "we" or the "Company") (NASDAQ: RRR)...

BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (Nasdaq: RPD), a leader in extended risk and threat detection, today...